Wall Street Experts
ver. ZuMIgo(08/25)
Legend Biotech Corporation
Rachunek Zysków i Strat
Przychody TTM (mln): 520
EBIT TTM (mln): -323
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
24 |
49 |
57 |
76 |
90 |
117 |
285 |
627 |
Przychód Δ r/r |
0.0% |
108.2% |
16.5% |
32.2% |
18.7% |
30.3% |
143.7% |
120.0% |
Marża brutto |
100.4% |
100.0% |
100.0% |
-206.8% |
-249.0% |
44.1% |
42.3% |
62.6% |
EBIT (mln) |
14 |
-2 |
-131 |
-313 |
-393 |
-456 |
-442 |
0 |
EBIT Δ r/r |
0.0% |
-111.1% |
8431.4% |
139.4% |
25.4% |
16.0% |
-3.0% |
-100.0% |
EBIT (%) |
58.4% |
-3.1% |
-228.5% |
-414.1% |
-437.7% |
-389.6% |
-155.1% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
4 |
1 |
11 |
22 |
22 |
EBITDA (mln) |
14 |
-7 |
-126 |
-303 |
-379 |
-437 |
-422 |
-113 |
EBITDA(%) |
59.3% |
-14.6% |
-219.4% |
-400.9% |
-422.2% |
-373.9% |
-147.9% |
-18.0% |
Podatek (mln) |
4 |
1 |
3 |
-4 |
0 |
1 |
-2 |
19 |
Zysk Netto (mln) |
9 |
-3 |
-133 |
-303 |
-386 |
-446 |
-518 |
-177 |
Zysk netto Δ r/r |
0.0% |
-129.7% |
4676.3% |
128.2% |
27.3% |
15.6% |
16.1% |
-65.8% |
Zysk netto (%) |
39.7% |
-5.7% |
-232.2% |
-401.0% |
-430.1% |
-381.5% |
-181.8% |
-28.2% |
EPS |
0.0709 |
-0.0278 |
-1.01 |
-2.57 |
-2.74 |
-2.81 |
-2.94 |
-0.97 |
EPS (rozwodnione) |
0.0709 |
-0.0278 |
-1.01 |
-2.57 |
-2.74 |
-2.81 |
-2.94 |
-0.97 |
Ilośc akcji (mln) |
132 |
100 |
132 |
118 |
141 |
159 |
176 |
183 |
Ważona ilośc akcji (mln) |
132 |
100 |
132 |
118 |
141 |
159 |
176 |
183 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |